AzTrials
AzTrials

Healthy SubjectCORTEXNCT03386188

Role of the Posterior Parietal Cortex in the Processing of Sensory Information

A study testing Transcranial Magnetic Stimulation (TMS) and Electrical Muscle Activity (EMG) in people with Healthy Subject, run by University Hospital, Lille at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Although the primary motor cortex is considered has the common final pathway of motor commands, it is influenced by several structures as, for example, the premotor cortex and the posterior parietal cortex which are involved in motor planning and programming and which integrates movement-induced sensory impute… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Subject
What is being tested?
Transcranial Magnetic Stimulation (TMS) and Electrical Muscle Activity (EMG)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
8 Jan 2016to 18 Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Right handed
  • No neurological troubles
  • Informed consent signed
  • Affiliated to a social security

Who cannot join

  • Psychiatric antecedent
  • Neurological disease
  • Contra-indication to TMS
  • Under psychiatric treatment
  • Pregnancy
  • Contra-indication to MRI

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Roger Salengro, CHRU de Lille

    Lille

Other trials in France

About this study

Official title: Role of the Posterior Parietal Cortex in the Processing of Sensory Information Modulating the Excitability of the Primary Motor Cortex in Humans

Although the primary motor cortex is considered has the common final pathway of motor commands, it is influenced by several structures as, for example, the premotor cortex and the posterior parietal cortex which are involved in motor planning and programming and which integrates movement-induced sensory impute (parieto-frontal circuits). Several studies have shown that there are some direct functional connections between the premotor cortex and the posterior parietal cortex and from these two regions to the primary motor cortex. The posterior parietal cortex can then be considered as a sensorimotor interface whose function in planification and motor control of upper limb is well demonstrated. The hypothesis is that the posterior parietal cortex could participate to the modulation of motor cortex excitability by proprioceptive sensory inputs namely long latency afferent inhibition and afferent induced facilitation.

Conditions
Healthy Subject
Being tested
Transcranial Magnetic Stimulation (TMS), Electrical Muscle Activity (EMG)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial Magnetic Stimulation (TMS)Device

    Transitory inactivation of the posterior parietal cortex and measure of sensorimotor integration.

  • Electrical Muscle Activity (EMG)Device

    Electrodes for the collection of EMG activity will be glued on the skin next to the first interosseus dorsalis muscle, the Abductor digiti minimi, the Extensor carpi radialis and the Abductor pollicis brevis. EMG signals will be stored on computer for off-line analysis using Signal © software (Cambridge Electronic Design, Cambridge, UK)

Study groups in NCT03386188
Study groupRoleWhat they receive
Healthy armExperimentalposterior parietal cortex (PPC) transitory inactivation
Receives: Device: Transcranial Magnetic Stimulation (TMS); Device: Electrical Muscle Activity (EMG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Afferent induced facilitation

    Motor cortex facilitation following median nerve stimulation at interstimulus intervals of 70ms

    Measured: Baseline

Secondary outcomes (1)
  1. Interaction between long latency afferent inhibition and long latency intracortical inhibition (LICI)

    Effect of median nerve stimulation on LICI at 100ms interval

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2017
  2. Study start8 Jan 2016
  3. Primary completion18 Jul 2021
  4. Study completion18 Jul 2021

Why it stopped: sponsor decision

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03386188
Sponsor's protocol ID
2014_32
Other IDs
2014-A01507-40
Acronym
CORTEX
Status last verified
Dec 2025
First submitted
14 Dec 2017
Last updated
22 Apr 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial Magnetic Stimulation (TMS) and Electrical Muscle Activity (EMG) in people with Healthy Subject, run by University Hospital, Lille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: sponsor decision). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Afferent induced facilitation (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in